case series:CAR-T cells
Sponsors
The Sixth Affiliated Hospital of Sun Yat-sen University, The Third Affiliated Hospital of Kunming Medical University, Wuxi People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions
AMLCD30+ Lymphoproliferative diseasesHematological malignancyadvanced solid tumorsrefractory or relapse B cell malignancies
Early Phase 1
Phase 2
Unknown Phase
A clinical study for anti-CD33 CAR-T cell therapy
RecruitingChiCTR-OPC-16009097
Start: 2016-08-25Updated: 2019-01-28
An open-label, single-center and single-arm clinical study of anti-CD19 CAR-T cells with immunosuppressive receptor knockdown in the treatment of refractory or recurrent B-cell malignancies
Active, not recruitingChiCTR1800019504
Start: 2018-12-01Updated: 2018-11-19
The clinical study of chimeric antigen receptor gene-modified autologous T cells for advanced solid tumors
RecruitingChiCTR2000040791
Start: 2019-09-01Updated: 2021-04-12
A clinical research of CAR-T cells targeting mesothelin and B7-H3 in the treatment of advanced solid tumors
Active, not recruitingChiCTR2100049630
Start: 2021-09-01Updated: 2022-04-19